| Acquirer | Target | Price |
|---|---|---|
| Biotechnology | ||
| Allergan plc | Naurex Inc. | $560 million |
| Pharmaceuticals | ||
| Teva Pharmacutical Industries Limited | Allergan Generics | $40.5 billion |
| Hikma Pharmaceuticals PLC | Roxane Laboratories, Inc. | $2.65 billion |
| Sanofi | Collaboration with Regeneron | $640 million |
| Source: Health Care M&A News, July 31, 2015 |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
